Availability and quality of data on drug policy and management of access to reimbursed medicinal products in the United Kingdom, Denmark, Germany, Italy and Poland
cytuj
pobierz pliki
RIS BIB ENDNOTEChoose format
RIS BIB ENDNOTEAvailability and quality of data on drug policy and management of access to reimbursed medicinal products in the United Kingdom, Denmark, Germany, Italy and Poland
Publication date: 2013
Public Health and Governance, 2013, Volume 11, Issue 1, pp. 89 - 99
https://doi.org/10.4467/20842627OZ.14.009.1619Authors
Availability and quality of data on drug policy and management of access to reimbursed medicinal products in the United Kingdom, Denmark, Germany, Italy and Poland
Objectives: To perform a systematic review, and to verify and define deficiencies in literature data on drug policy and management of access to reimbursed medicinal products in the United Kingdom, Denmark, Germany, Italy and Poland as a source of information intended to be used by government authorities in the decision-making process.
Methods: A systematic review was conducted through database search of Medline, SCOPUS, Embase and Cochrane Library, supplemented by nonsystematic review. The quality of the identified literature was critically appraised.
Results: Information necessary to develop a knowledge base was outline from 121 papers identified through database search. 0.83% of all publications were rated high in all of the assessed categories, i.e. were identified to represent high levels of consistency, coherence, strength and methodological quality.
Conclusions: In the policy decision-making process, concise recommendations based on validated data are more than needed. It is vital to rely on scientific evidence and avoid reports based on simple exchange of information or presenting single-source or unconfirmed data, including expert’s opinion.
Information: Public Health and Governance, 2013, Volume 11, Issue 1, pp. 89 - 99
Article type: Original article
Titles:
Availability and quality of data on drug policy and management of access to reimbursed medicinal products in the United Kingdom, Denmark, Germany, Italy and Poland
Availability and quality of data on drug policy and management of access to reimbursed medicinal products in the United Kingdom, Denmark, Germany, Italy and Poland
Medical University of Warsaw
ul. Żwirki i Wigury 61, 02-091 Warszawa, Poland
National Institute of Public Health, ul. Chocimska 24, 00-791 Warszawa
Medical University of Warsaw
ul. Żwirki i Wigury 61, 02-091 Warszawa, Poland
Medical University of Warsaw
ul. Żwirki i Wigury 61, 02-091 Warszawa, Poland
Medical University of Warsaw
ul. Żwirki i Wigury 61, 02-091 Warszawa, Poland
Published at: 2013
Article status: Open
Licence: None
Percentage share of authors:
Article corrections:
-Publication languages:
EnglishView count: 2670
Number of downloads: 1070